| Peer groups | Experienced groups | P value | ||||
---|---|---|---|---|---|---|---|
 | Control | DMF | JH | Control | DMF | JH |  |
Total HDT per group | 70.8±10 | 48.9±15.1 | 52.1±16.8 | 50.75±12.2 | 54.2±12.1 | 37.3±7.3 | p=0.56; p=0.341 |
n=10 | n=10 | n=7 | n=8 | n=10 | n=9 | ||
HDT performed by IW | 36.9±13.6 | 30.6±12.1 | 35.7±15 | 14.2±3.5 | 6.3±2.3 | 4.5±1.1 | p=0.97; p=0.022 |
n=10 | n=10 | n=7 | n=8 | n=10 | n=9 | ||
HDT received by IW | 32.4±8.2 | 33.7±7.1 | 20.3±6.8 | 40.5±3.5 | 42.1±6.9 | 42±5.2 | p=0.61; p=0.293 |
n=10 | n=10 | n=7 | n=8 | n=10 | n=9 | ||
Percentage of HDT in which IW was involved | 50.6±10.9% | 35.8±15.8% | 32.1±13.4% | 26.25±6.1% | 26.9±7.4% | 17.4±3.9% | P=0.84; p=0.0264 |
n=10 | n=10 | n=7 | n=8 | n=10 | n=9 | ||
Ovarian activation of IW (4 days) | 0.14±0.01 | 0.12±0.01 | 0.17±0.01 | 0.17±0.02 | 0.16±0.02 | 0.13±0.02 | p=0.13; p=0.685 |
n=29 | n=28 | n=26 | n=8 | n=10 | n=9 | ||
Ovarian activation of IW (7 days) | 2.24±0.2 | - | - | 1.47±0.23 | - | - | t-test: t=2.46, p=0.01 |
(n=15) | Â | Â | (n=16) | Â | Â |